CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($) $ in Thousands	Total		Total Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests
Balance at the beginning of the period (in shares) at Dec. 31, 2022				56,226,273
Balance at the beginning of the period at Dec. 31, 2022	$ 3,606,112		$ 3,540,499	$ 564	$ 3,972,561	$ 168,077	$ 10,335	$ (611,038)	$ 65,613
Balance at the beginning of the period (in shares) at Dec. 31, 2022								(6,424,276)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(41,768)		(41,888)			(41,888)			120
Interest rate caps and swaps	(2,582)	[1]	(2,582)				(2,582)
Teravalis noncontrolling interest	117								117
Stock plan activity (in shares)				306,757				(20,472)
Stock plan activity	6,596		6,596	$ 2	8,219			$ (1,625)
Other	(22)								(22)
Balance at the end of the period (in shares) at Jun. 30, 2023				56,533,030
Balance at the end of the period at Jun. 30, 2023	3,568,453		3,502,625	$ 566	3,980,780	126,189	7,753	$ (612,663)	65,828
Balance at the end of the period (in shares) at Jun. 30, 2023								(6,444,748)
Balance at the beginning of the period (in shares) at Mar. 31, 2023				56,427,928
Balance at the beginning of the period at Mar. 31, 2023	3,582,523		3,516,758	$ 566	3,977,514	145,332	5,005	$ (611,659)	65,765
Balance at the beginning of the period (in shares) at Mar. 31, 2023								(6,431,442)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(19,141)		(19,143)			(19,143)			2
Interest rate caps and swaps	2,748	[1]	2,748				2,748
Teravalis noncontrolling interest	61								61
Stock plan activity (in shares)				105,102				(13,306)
Stock plan activity	2,262		2,262		3,266			$ (1,004)
Balance at the end of the period (in shares) at Jun. 30, 2023				56,533,030
Balance at the end of the period at Jun. 30, 2023	$ 3,568,453		3,502,625	$ 566	3,980,780	126,189	7,753	$ (612,663)	65,828
Balance at the end of the period (in shares) at Jun. 30, 2023								(6,444,748)
Balance at the beginning of the period (in shares) at Dec. 31, 2023	50,038,014			56,495,791
Balance at the beginning of the period at Dec. 31, 2023	$ 3,058,924		2,992,871	$ 565	3,988,496	(383,696)	1,272	$ (613,766)	66,053
Balance at the beginning of the period (in shares) at Dec. 31, 2023	(6,457,777)							(6,457,777)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	$ (31,409)		(31,385)			(31,385)			(24)
Interest rate caps and swaps	2,663	[1]	2,663				2,663
Teravalis noncontrolling interest	117								117
Stock plan activity (in shares)				213,869				(15,461)
Stock plan activity	$ 6,424		6,424	$ 2	7,630			$ (1,208)
Balance at the end of the period (in shares) at Jun. 30, 2024	50,236,422			56,709,660
Balance at the end of the period at Jun. 30, 2024	$ 3,036,719		2,970,573	$ 567	3,996,126	(415,081)	3,935	$ (614,974)	66,146
Balance at the end of the period (in shares) at Jun. 30, 2024	(6,473,238)							(6,473,238)
Balance at the beginning of the period (in shares) at Mar. 31, 2024				56,714,750
Balance at the beginning of the period at Mar. 31, 2024	$ 3,012,755		2,946,625	$ 567	3,993,152	(436,173)	3,897	$ (614,818)	66,130
Balance at the beginning of the period (in shares) at Mar. 31, 2024								(6,471,011)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	21,058		21,092			21,092			(34)
Interest rate caps and swaps	38	[1]	38				38
Teravalis noncontrolling interest	50								50
Stock plan activity (in shares)				(5,090)				(2,227)
Stock plan activity	$ 2,818		2,818		2,974			$ (156)
Balance at the end of the period (in shares) at Jun. 30, 2024	50,236,422			56,709,660
Balance at the end of the period at Jun. 30, 2024	$ 3,036,719		$ 2,970,573	$ 567	$ 3,996,126	$ (415,081)	$ 3,935	$ (614,974)	$ 66,146
Balance at the end of the period (in shares) at Jun. 30, 2024	(6,473,238)							(6,473,238)

[1] Amounts are shown net of tax expense of $10.0 thousand for the three months ended June 30, 2024, tax expense of $0.8 million for the six months ended June 30, 2024, tax expense of $0.8 million for the three months ended June 30, 2023, and tax benefit of $0.8 million for the six months ended June 30, 2023.